1. Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?

   • Sunitha Kodidela
   • Pradhan Suresh Chandra
   • Biswajit Dubashi

   Review Article 27 December 2013 Pages: 253 - 260

   

2. Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy

   • Nadav Willner
   • Shimon Storch
   • Elad Schiff

   Special Article 26 November 2013 Pages: 261 - 263

   

3. Improved accuracy of anticoagulant dose prediction using a pharmacogenetic and artificial neural network-based method

   • Hussain A. Isma’eel
   • George E. Sakr
   • Imad H. Elhajj

   Pharmacogenetics 03 December 2013 Pages: 265 - 273

   

4. HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique

   • Paola Borgiani
   • Davide Di Fusco
   • Cinzia Ciccacci

   Pharmacogenetics 10 December 2013 Pages: 275 - 278

   

5. Effect of moderate liver impairment on the pharmacokinetics of opicapone

   • José Francisco Rocha
   • Ana Santos
   • Patrício Soares-da-Silva

   Pharmacokinetics and Disposition 24 November 2013 Pages: 279 - 286

   

6. Effects of ponesimod, a selective S1P₁ receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive

   • Maribel Reyes
   • Patrick Brossard
   • Jasper Dingemanse

   Pharmacokinetics and Disposition 22 December 2013 Pages: 287 - 293

   

7. Persistence of antihypertensive drug use in German primary care: a follow-up study based on pharmacy claims data

   • Thomas Grimmsmann
   • Wolfgang Himmel

   Pharmacoepidemiology and Prescription 26 November 2013 Pages: 295 - 301

   

8. Compliance with quality prescribing indicators linked to financial incentives: what about not incentivized indicators?: an observational study

   • R. Fernández Urrusuno
   • P. Pérez Pérez
   • B. Pascual de la Pisa

   Pharmacoepidemiology and Prescription 03 December 2013 Pages: 303 - 311

9. Checklist for standardized reporting of drug–drug interaction management guidelines

   • Annemieke Floor-Schreudering
   • Arjen F. J. Geerts
   • Peter A. G. M. De Smet

   Pharmacoepidemiology and Prescription 05 December 2013 Pages: 313 - 318

10. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults

    • Juha Puustinen
    • Ritva Lähteenmäki
    • Sirkka-Liisa Kivelä

    Pharmacoepidemiology and Prescription 12 December 2013 Pages: 319 - 329

    

11. Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level

    • Daniele Piovani
    • Antonio Clavenna
    • on behalf of the Interregional Italian Drug Utilisation Group

    Pharmacoepidemiology and Prescription 06 December 2013 Pages: 331 - 337

    

12. Drug-induced agranulocytosis in the Berlin case–control surveillance study

    • Matthias Huber
    • Frank Andersohn
    • Edeltraut Garbe

    Pharmacoepidemiology and Prescription 03 December 2013 Pages: 339 - 345

    

13. The quality of outpatient antimicrobial prescribing: a comparison between two areas of northern and southern Europe

    • Sara Malo
    • Lars Bjerrum
    • María José Rabanaque-Hernández

    Pharmacoepidemiology and Prescription 10 December 2013 Pages: 347 - 353

    

14. Fetal safety of erythromycin. An update of Swedish data

    • Bengt Källén
    • Bengt R. Danielsson

    Pharmacoepidemiology and Prescription 20 December 2013 Pages: 355 - 360

    

15. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission

    • Consuelo Pedrós
    • Beatriz Quintana
    • Josep Maria Arnau

    Pharmacoepidemiology and Prescription 21 December 2013 Pages: 361 - 367

16. On the possible interaction between vaccines and drugs

    • Paolo Pellegrino
    • Carla Carnovale
    • Sonia Radice

    Letter to the Editors 05 December 2013 Pages: 369 - 371

17. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis – insights into possible drug mechanism

    • Victor Voon
    • Lavanya Saiva
    • David Keane

    Letter to the Editors 06 December 2013 Pages: 373 - 375

    

18. Pharmacokinetic changes after placement of a transjugular intrahepatic portosystemic shunt

    • Sabrina De Winter
    • Sandra Verelst
    • Isabel Spriet

    Letter to the Editors 19 December 2013 Pages: 377 - 378